We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-31.28%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$305M
AUM Growth
-$185M
Cap. Flow
+$5.37M
Cap. Flow %
1.76%
Top 10 Hldgs %
72.94%
Holding
68
New
2
Increased
1
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$9.33M
2
WMS icon
Advanced Drainage Systems
WMS
+$4.63M
3
AVDX
AvidXchange
AVDX
+$8

Top Sells

Rank Stock Value
1
KLDO
Kaleido Biosciences, Inc. Common Stock
KLDO
+$3.03M
2
ROVR
Rover Group, Inc. Class A Common Stock
ROVR
+$1.87M
3
BILL icon
BILL Holdings
BILL
+$1.79M
4
YEXT icon
Yext
YEXT
+$793K
5
ROOT icon
Root
ROOT
+$402K

Sector Composition

Rank Sector Weight
1 Technology 57.05%
2 Consumer Discretionary 17.47%
3 Healthcare 15.39%
4 Industrials 3.57%
5 Communication Services 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASTR
51
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$243K 0.08%
12,444
– –
OPEN icon
52
Opendoor
OPEN
$3.66B
$220K 0.07%
48,264
– –
DCT
53
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$215K 0.07%
14,508
– –
RPTX
54
DELISTED
Repare Therapeutics
RPTX
$172K 0.06%
12,276
– –
MCRB icon
55
Seres Therapeutics
MCRB
$46.5M
$169K 0.06%
2,468
– –
PMVP icon
56
PMV Pharmaceuticals
PMVP
$57.6M
$164K 0.05%
11,533
– –
DASH icon
57
DoorDash
DASH
$84.4B
$161K 0.05%
2,505
– –
IPSC icon
58
Century Therapeutics
IPSC
$368M
$123K 0.04%
14,631
– –
PACB icon
59
Pacific Biosciences
PACB
$441M
$104K 0.03%
23,484
– –
OYST
60
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$54K 0.02%
12,560
– –
NXTC icon
61
NextCure
NXTC
$22.3M
$47K 0.02%
837
– –
ALGS icon
62
Aligos Therapeutics
ALGS
$26.9M
$23K 0.01%
751
– –
BILL icon
63
BILL Holdings
BILL
$4.75B
– –
-7,888
Closed -$1.79M
ROOT icon
64
Root
ROOT
$902M
– –
-11,351
Closed -$402K
VCTR icon
65
Victory Capital Holdings
VCTR
$6.15B
– –
-11,978
Closed -$346K
YEXT icon
66
Yext
YEXT
$569M
– –
-115,147
Closed -$793K
ROVR
67
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
– –
-324,145
Closed -$1.87M
KLDO
68
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
– –
-1,833,832
Closed -$3.03M
1 2
3

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Harbourvest Partners held 68 positions worth $305M, down 38% from $490M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Harbourvest Partners's Q2 2022 filing shows 2 new, 1 increased, 2 reduced and 6 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 231,288 shares worth $6.81M. The largest sale was Kaleido Biosciences, Inc. Common Stock, an estimated $3.03M.

By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q2 2022 buy was HashiCorp, Inc. Class A Common Stock: 231,288 shares worth $6.81M.
  • Harbourvest Partners added most to AvidXchange in Q2 2022, an estimated $8 increase.
  • Harbourvest Partners's biggest Q2 2022 reduction was Flywire, cutting an estimated $232K.
  • Harbourvest Partners fully exited Kaleido Biosciences, Inc. Common Stock in Q2 2022, selling an estimated $3.03M.
  • Harbourvest Partners's ten largest holdings make up 73% of its $305M portfolio in Q2 2022.
  • Harbourvest Partners opened 2 new positions and closed 6 in Q2 2022.
  • Harbourvest Partners's portfolio value fell 38% quarter-over-quarter to $305M.

Based on Harbourvest Partners's 13F filing for Q2 2022, filed 15 Aug 2022.